Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 44

1.

Using an innovative curriculum evaluation tool to inform program improvement: the clinical skills fair.

Narayan AP, Whicker SA, Staples BB, Bookman J, Bartlett KW, McGann KA.

J Grad Med Educ. 2014 Mar;6(1):133-8. doi: 10.4300/JGME-D-13-00190.1.

PMID:
24701324
[PubMed]
2.

The impact of HAART on cardiomyopathy among children and adolescents perinatally infected with HIV-1.

Patel K, Van Dyke RB, Mittleman MA, Colan SD, Oleske JM, Seage GR 3rd; International Maternal Pediatric Adolescent AIDS Clinical Trials 219219C Study Team.

AIDS. 2012 Oct 23;26(16):2027-37. doi: 10.1097/QAD.0b013e3283578bfa.

PMID:
22781228
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

An innovative process for faculty development in residency training.

Narayan AP, Whicker SA, McGann KA.

Teach Learn Med. 2012;24(3):248-56. doi: 10.1080/10401334.2012.692280.

PMID:
22775790
[PubMed - indexed for MEDLINE]
4.

Immunogenicity and safety of 1 vs 2 doses of quadrivalent meningococcal conjugate vaccine in youth infected with human immunodeficiency virus.

Lujan-Zilbermann J, Warshaw MG, Williams PL, Spector SA, Decker MD, Abzug MJ, Heckman B, Manzella A, Kabat B, Jean-Philippe P, Nachman S, Siberry GK; International Maternal Pediatric Adolescent AIDS Clinical Trials Group P1065 Protocol Team.

J Pediatr. 2012 Oct;161(4):676-81.e2. doi: 10.1016/j.jpeds.2012.04.005. Epub 2012 May 22.

PMID:
22622049
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Do pediatric residents prefer interactive learning? Educational challenges in the duty hours era.

Turner DA, Narayan AP, Whicker SA, Bookman J, McGann KA.

Med Teach. 2011;33(6):494-6. doi: 10.3109/0142159X.2010.542524. Epub 2011 Feb 28.

PMID:
21355697
[PubMed - indexed for MEDLINE]
6.

Medication adherence in children and adolescents with HIV infection: associations with behavioral impairment.

Malee K, Williams P, Montepiedra G, McCabe M, Nichols S, Sirois PA, Storm D, Farley J, Kammerer B; PACTG 219C Team.

AIDS Patient Care STDS. 2011 Mar;25(3):191-200. doi: 10.1089/apc.2010.0181. Epub 2011 Feb 16.

PMID:
21323533
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Phase I/II, open-label trial of safety and immunogenicity of meningococcal (groups A, C, Y, and W-135) polysaccharide diphtheria toxoid conjugate vaccine in human immunodeficiency virus-infected adolescents.

Siberry GK, Williams PL, Lujan-Zilbermann J, Warshaw MG, Spector SA, Decker MD, Heckman BE, Demske EF, Read JS, Jean-Philippe P, Kabat W, Nachman S; IMPAACT P1065 Protocol Team.

Pediatr Infect Dis J. 2010 May;29(5):391-6. doi: 10.1097/INF.0b013e3181c38f3b.

PMID:
20431379
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Neurodevelopment and in utero antiretroviral exposure of HIV-exposed uninfected infants.

Williams PL, Marino M, Malee K, Brogly S, Hughes MD, Mofenson LM; PACTG 219C Team.

Pediatrics. 2010 Feb;125(2):e250-60. doi: 10.1542/peds.2009-1112. Epub 2010 Jan 18.

PMID:
20083530
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

The use of second-generation antipsychotics and the changes in physical growth in children and adolescents with perinatally acquired HIV.

Kapetanovic S, Aaron L, Montepiedra G, Sirois PA, Oleske JM, Malee K, Pearson DA, Nichols SL, Garvie PA, Farley J, Nozyce ML, Mintz M, Williams PL; Pediatric AIDS Clinical Trials.

AIDS Patient Care STDS. 2009 Nov;23(11):939-47. doi: 10.1089/apc.2009.0121.

PMID:
19827949
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Impact of medications prescribed for treatment of attention-deficit hyperactivity disorder on physical growth in children and adolescents with HIV.

Sirois PA, Montepiedra G, Kapetanovic S, Williams PL, Pearson DA, Malee K, Garvie PA, Kammerer BL, Nichols SL, Nozyce ML, Mintz M, Mitchell WG, Oleske JM; IMPAACT/PACTG 219C Team.

J Dev Behav Pediatr. 2009 Oct;30(5):403-12.

PMID:
19827220
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Impact of HAART and CNS-penetrating antiretroviral regimens on HIV encephalopathy among perinatally infected children and adolescents.

Patel K, Ming X, Williams PL, Robertson KR, Oleske JM, Seage GR 3rd; International Maternal Pediatric Adolescent AIDS Clinical Trials 219/219C Study Team.

AIDS. 2009 Sep 10;23(14):1893-901. doi: 10.1097/QAD.0b013e32832dc041.

PMID:
19644348
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Randomized controlled trial of feeding a concentrated formula to infants born to women infected by human immunodeficiency virus.

Winter HS, Oleske JM, Hughes MD, McKinney RE Jr, Elgie C, Powell C, Purdue L, Puga AM, Jimenez E, Scott GB, Cruz ML, Moye J Jr; Pediatric AIDS Clinical Trials Group Protocol 247 Study Team.

J Pediatr Gastroenterol Nutr. 2009 Aug;49(2):222-32. doi: 10.1097/MPG.0b013e3181928937.

PMID:
19543114
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Incidence of noninfectious conditions in perinatally HIV-infected children and adolescents in the HAART era.

Nachman SA, Chernoff M, Gona P, Van Dyke RB, Dankner WM, Seage GR 3rd, Oleske J, Williams PL; PACTG 219C Team.

Arch Pediatr Adolesc Med. 2009 Feb;163(2):164-71. doi: 10.1001/archpedi.163.2.164. Erratum in: Arch Pediatr Adolesc Med. 2009 Apr;163(4):364.

PMID:
19188649
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Toxicities associated with dual nucleoside reverse-transcriptase inhibitor regimens in HIV-infected children.

Van Dyke RB, Wang L, Williams PL; Pediatric AIDS Clinical Trials Group 219C Team.

J Infect Dis. 2008 Dec 1;198(11):1599-608. doi: 10.1086/593022.

PMID:
19000014
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Safety and immunogenicity of recombinant poxvirus HIV-1 vaccines in young adults on highly active antiretroviral therapy.

Greenough TC, Cunningham CK, Muresan P, McManus M, Persaud D, Fenton T, Barker P, Gaur A, Panicali D, Sullivan JL, Luzuriaga K; Pediatric AIDS Clinical Trials Group P1059 Team.

Vaccine. 2008 Dec 9;26(52):6883-93. doi: 10.1016/j.vaccine.2008.09.084. Epub 2008 Oct 20.

PMID:
18940219
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Long-term effects of highly active antiretroviral therapy on CD4+ cell evolution among children and adolescents infected with HIV: 5 years and counting.

Patel K, HernĂ¡n MA, Williams PL, Seeger JD, McIntosh K, Dyke RB, Seage GR 3rd; Pediatric AIDS Clinical Trials Group 219/219C Study Team.

Clin Infect Dis. 2008 Jun 1;46(11):1751-60. doi: 10.1086/587900.

PMID:
18426371
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Association of site-specific and participant-specific factors with retention of children in a long-term pediatric HIV cohort study.

Williams PL, Van Dyke R, Eagle M, Smith D, Vincent C, Ciupak G, Oleske J, Seage GR 3rd; PACTG 219C Team.

Am J Epidemiol. 2008 Jun 1;167(11):1375-86. doi: 10.1093/aje/kwn072. Epub 2008 Apr 15.

PMID:
18413359
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Association of hypercholesterolemia incidence with antiretroviral treatment, including protease inhibitors, among perinatally HIV-infected children.

Tassiopoulos K, Williams PL, Seage GR 3rd, Crain M, Oleske J, Farley J; International Maternal Pediatric Adolescent AIDS Clinical Trials 219C Team.

J Acquir Immune Defic Syndr. 2008 Apr 15;47(5):607-14. doi: 10.1097/QAI.0b013e3181648e16.

PMID:
18209684
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Mapping students' clinical experiences to pediatric clerkship goals.

Lee A, Sharkey A, McGann K, Sumner W 2nd.

AMIA Annu Symp Proc. 2006:1003.

PMID:
17238622
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Complications of human immunodeficiency virus therapy.

Hayes EV, McGann KA.

Pediatr Infect Dis J. 2004 Sep;23(9):873-4. Review. No abstract available.

PMID:
15361730
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk